August Bioservices Closes $23.6 Million Series A Extension to Expand U.S. Biopharma Manufacturing Capabilities - read this article along with other careers information, tips and advice on BioSpace
August Bioservices Closes $23 6 Million Series A Extension to Expand U S Biopharma Manufacturing Capabilities streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
August Bioservices, a Nashville, Tenn.-based contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6m Series A extension.
The round was led by Polaris Partners, who joined existing investor Oak HC/FT. As part of the financing, Brian Chee, Managing Partner of Polaris Partners, joined the August Bioservices’ board as a Director. Darren Carroll of Polaris Partners joined the board as an observer.
The company intends to use the funds to expand its manufacturing capacity and capabilities to advance the technology platforms needed to support production of sterile injectable medications.
Led by Jenn Adams, CEO, August Bioservices partners with biopharmaceutical and biotech companies to provide a wide array of services to accelerate the advancement of novel therapeutics along the drug development pathway. Its service portfolio includes cGMP non-sterile and bulk manufacturing, aseptic fil